General Information of the Compound
| Compound ID |
CP0399081
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-amino-3-[5-[2-[[3-(aminomethyl)phenyl]methyl]tetrazol-5-yl]-3-oxo-1,2-oxazol-4-yl]propanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H17N7O4
|
||||||||||||||||||
| Molecular Weight |
359.346
|
||||||||||||||||||
| Canonical SMILES |
NCc1cccc(Cn2nnc(n2)-c2onc(O)c2C[C@H](N)C(O)=O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H17N7O4/c16-6-8-2-1-3-9(4-8)7-22-19-13(18-21-22)12-10(14(23)20-26-12)5-11(17)15(24)25/h1-4,11H,5-7,16-17H2,(H,20,23)(H,24,25)/t11-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RVAKWTBISFVYTO-NSHDSACASA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02409, Glutamate receptor 1
Protein ID: PT01414, Glutamate receptor 2
Protein ID: PT03116, Glutamate receptor 3
Protein ID: PT06060, Glutamate receptor 4
Protein ID: PT02201, Glutamate receptor ionotropic, kainate 2
Protein ID: PT02970, Glutamate receptor ionotropic, kainate 3